Lorem ipsum dolor sit amet gravida nibh vel velit auctor aliquet. Aenean sollicitudin, lorem quis bibendum auci. Proin gravida nibh vel veliau ctor aliquenean.

Follow me on instagram

+01145928421
mymail@gmail.com

March 2018

  NEWPORT BEACH, CA. (March 28, 2018) — Integrated Oncology Network Holdings, LLC (“ION”), the parent company of SightLine Health, LLC along with other SightLIne subsidiaries (”SightLine”), announced today that they have reached final agreement to end a more than 5 year investigation by the Office of Inspector General and to settle a civil litigation matter brought by a Qui Tam Whistleblower in November 2016. The government investigation and the subsequent Whistleblower lawsuit alleged that SightLine engaged in conduct that caused the submission of false claims to the United States based on the manner in which SightLine allegedly offered and provided kickbacks in the form of investment opportunities and ownership dividends in independent, turnkey radiation oncology clinics. Although ION disputes the DOJ’s allegations, ION elected to settle in order to avoid the cost and uncertainty of continued litigation, as well as the distraction